간질환 진단 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 7.4%의 성장률(CAGR)을 기록하며 520억 4,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안 예상되는 성장의 원동력은 노인 인구 증가, R&D 지출 증가, 생검 시술 횟수 및 관련 질환 증가, 원격 의료의 광범위한 채택 등의 요인으로 인해 발생할 것으로 예측됩니다. 이 기간 동안 예상되는 주요 동향으로는 개인 맞춤형 의료의 부상, 진단 키트의 기술적 진보, 신속 검사의 혁신, 헬스케어 기술의 발전, 진단 방법의 개선 등이 있습니다.
알코올 소비 증가는 간질환 진단제 시장의 성장을 견인할 것으로 예측됩니다. 알코올 소비는 사회적 규범의 변화, 더 저렴한 가격, 광범위한 가용성, 스트레스 및 정신 건강 문제 증가 등으로 인해 증가하고 있습니다. 알코올 소비는 간 건강에 영향을 미치기 때문에 지방간, 간염, 간경변증 등 간 손상의 징후를 조기에 발견할 수 있는 진단 도구가 필수적입니다. 예를 들어, 2022년 12월 국민보건서비스(NHS)에 따르면, 알코올 소비는 연령에 따라 증가하여 16세에서 24세 사이의 62%가 지난 12개월 동안 알코올 소비를 보고했으며, 55세에서 74세 사이의 85%가 알코올 소비에 종사하고 있다고 보고했습니다. 이러한 추세는 간 건강 상태의 조기 발견 및 모니터링에 대한 필요성이 높아지면서 간질환 진단약 시장의 성장에 기여하고 있습니다.
간 질환 진단 시장 기업들은 간 상태를 평가할 수 있는 혁신적인 비침습적 도구 개발에 주력하고 있습니다. 이러한 도구는 생검과 같은 침습적 시술 없이도 정확하고 효율적인 진단 방법을 제공합니다. 예를 들어, 2024년 9월 인도의 진단센터인 City Imaging &&Clinical은 비알코올성 지방간질환(NAFLD), 알코올성 간질환(ALD) 등 간질환의 조기 발견을 위한 비침습적 진단 도구인 FibroScan을 출시했습니다. FibroScan은 엘라스토그래피 기술을 이용해 간 경도와 지방 함량을 빠르고 정확하게 측정하여 기존 생검을 대체할 수 있는 비침습적 방법을 제공합니다. 시술 시간은 5-15분 정도 소요되며, 프로브를 간에 대고 음파를 발생시켜 간 조직의 경도를 평가하여 섬유증이나 흉터와 같은 상태를 조기에 진단할 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 간질환 진단 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 간질환 진단 시장 : 성장률 분석
- 세계의 간질환 진단 시장 실적 : 규모와 성장, 2019-2024
- 세계의 간질환 진단 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계의 간질환 진단 TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 간질환 진단 시장 : 진단 기술별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 임상 검사
- 영상 진단
- 내시경 검사
- 생검
- 기타 진단 기술
- 세계의 간질환 진단 시장 : 질환별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 비알코올성 지방성 간질환
- 비알코올성 지방간염
- 섬유증
- 간경변
- 간세포암
- 기타 병
- 세계의 간질환 진단 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 연구소
- 기타 최종사용자
- 세계의 간질환 진단 시장 : 임상 검사 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 혈액검사(간기능 검사, 간염 패널)
- 효소 검사(ALT, AST, ALP)
- 유전자 검사
- 혈청학적 검사
- 세계의 간질환 진단 시장 : 이미징별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 초음파 영상 진단
- CT 스캔
- MRI
- 에러 파업 그래피(FibroScan)
- 세계의 간질환 진단 시장 : 내시경검사 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 식도위십이지장경 검사(EGD)
- 캡슐 내시경검사
- 세계의 간질환 진단 시장 : 생검 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 간생검(침생검)
- 세침 흡인 생검
- 복강경하 생검
- 세계의 간질환 진단 시장 : 기타 진단 기술 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 분자 이미징
- 바이오마커 검사
- 섬유증 스코어 링 시스템
제7장 지역별/국가별 분석
- 세계의 간질환 진단 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 간질환 진단 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 간질환 진단 시장 : 경쟁 구도
- 간질환 진단 시장 : 기업 개요
- F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
- Echosens SA Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- Boston Scientific Corporation
- Laboratory Corporation of America Holdings
- Quest Diagnostics Incorporated
- Siemens Healthineers AG
- bioMerieux SA
- Genentech Inc.
- Perspectum Diagnostics Ltd.
- Owlstone Medical Ltd.
- Enterome SA
- Atlentis Therapeutics AG
- 89bio Inc.
- Aligos Therapeutics Inc.
- BioPredictive SAS
- Cosara Diagnostics Pvt. Ltd.
- Hepion Pharmaceuticals Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 간질환 진단 시장(2029년) : 새로운 기회를 제공하는 국가
- 간질환 진단 시장(2029년) : 새로운 기회를 제공하는 부문
- 간질환 진단 시장(2029년) : 성장 전략
제36장 부록
LSH
Liver disease diagnostics encompass the medical procedures and tests used to detect and evaluate a range of liver conditions, such as liver cirrhosis, hepatitis, fatty liver disease, and liver cancer. These diagnostic methods typically include blood tests to measure liver enzyme levels, imaging techniques such as ultrasound or CT scans, and occasionally biopsy procedures to collect tissue samples.
The primary diagnostic techniques for liver disease include laboratory tests, imaging, endoscopy, biopsy, and other methods. Laboratory tests involve analyzing blood and other samples to identify liver conditions. These tests are used to diagnose diseases such as non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, fibrosis, cirrhosis, hepatocellular carcinoma, and more. They are utilized by a variety of end users, including hospitals, laboratories, and other healthcare settings.
The liver disease diagnostics market research report is one of a series of new reports from The Business Research Company that provides liver disease diagnostics market statistics, including liver disease diagnostics industry global market size, regional shares, competitors with a liver disease diagnostics market share, detailed liver disease diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the liver disease diagnostics industry. This liver disease diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The liver disease diagnostics market size has grown strongly in recent years. It will grow from $36.26 billion in 2024 to $39.05 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historical period can be attributed to factors such as the rising prevalence of both acute and chronic liver conditions, an increase in liver diseases, higher alcohol consumption, growing awareness of liver health, and the expansion of healthcare infrastructure.
The liver disease diagnostics market size is expected to see strong growth in the next few years. It will grow to $52.04 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The anticipated growth in the forecast period is driven by factors including the increasing geriatric population, higher spending on research and development, a rise in the number of biopsy procedures and related diseases, and the broader adoption of telemedicine. Key trends expected during this period include the rise of personalized medicine, technological advancements in diagnostic kits, innovations in rapid testing, progress in healthcare technologies, and improvements in diagnostic methods.
The rise in alcohol consumption is expected to drive the growth of the liver disease diagnostics market. Alcohol consumption has increased due to changing social norms, greater affordability, widespread availability, and rising stress or mental health challenges. As alcohol consumption impacts liver health, diagnostic tools are essential for detecting early signs of liver damage, such as fatty liver, hepatitis, or cirrhosis. For example, according to the National Health Service (NHS) in December 2022, alcohol consumption rose with age, with 62% of individuals aged 16 to 24 reporting consumption in the past 12 months, and 85% of individuals aged 55 to 74 engaging in alcohol consumption. This trend is contributing to the growth of the liver disease diagnostics market, as there is a greater need for early detection and monitoring of liver health.
Companies in the liver disease diagnostics market are focusing on the development of innovative, non-invasive tools to assess liver conditions. These tools provide accurate and efficient diagnostic methods without the need for invasive procedures such as biopsies. For instance, in September 2024, City Imaging & Clinical, an India-based diagnostic center, launched FibroScan, a non-invasive diagnostic tool aimed at the early detection of liver diseases such as non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). FibroScan uses elastography technology to measure liver stiffness and fat content quickly and accurately, offering a non-invasive alternative to traditional biopsies. The procedure takes only 5 to 15 minutes and involves placing a probe over the liver, which emits sound waves to assess liver tissue stiffness, enabling early diagnosis of conditions such as fibrosis or scarring.
In August 2024, Quest Diagnostics, a US-based medical laboratory company, acquired LifeLabs for $1 billion. This acquisition is expected to significantly enhance Quest Diagnostics' operational capabilities and expand its healthcare services in Canada. LifeLabs, a Canada-based laboratory company, specializes in liver disease diagnostics, particularly focusing on conditions such as non-alcoholic fatty liver disease (NAFLD), and the acquisition will help broaden Quest's diagnostic offerings in this area.
Major players in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Echosens SA, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG, bioMerieux SA, Genentech Inc., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., Enterome SA, Atlentis Therapeutics AG, 89bio Inc., Aligos Therapeutics Inc., BioPredictive SAS, Cosara Diagnostics Pvt. Ltd., Hepion Pharmaceuticals Inc., HEPQuant LLC, and Aiforia Technologies Plc.
North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in liver disease diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the liver disease diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The liver disease diagnostics market consists of revenues earned by entities by providing services such as liver disease diagnostics, imaging studies, fibrosis assessment, viral hepatitis screening, and alcohol-related liver disease evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. The liver disease diagnostics market also includes sales of blood test kits, imaging devices, and biopsy needles and instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Liver Disease Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on liver disease diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for liver disease diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The liver disease diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Diagnosis Technique: Laboratory Tests; Imaging; Endoscopy; Biopsy; Other Diagnosis Techniques
- 2) By Disease: Non-Alcoholic Fatty Liver Disease; Non-Alcoholic Steatohepatitis; Fibrosis; Cirrhosis; Hepatocellular Carcinoma; Other Diseases
- 3) By End Users: Hospitals; Laboratories; Other End Users
- Subsegments:
- 1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel); Enzyme Tests (ALT, AST, ALP); Genetic Testing; Serological Tests
- 2) By Imaging: Ultrasound Imaging; CT Scans; MRI; Elastography (FibroScan)
- 3) By Endoscopy: Esophagogastroduodenoscopy (EGD); Capsule Endoscopy
- 4) By Biopsy: Liver Biopsy (Needle Biopsy); Fine Needle Aspiration Biopsy; Laparoscopic Biopsy
- 5) By Other Diagnosis Techniques: Molecular Imaging; Biomarker Testing; Fibrosis Scoring Systems
- Companies Mentioned: F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Thermo Fisher Scientific Inc.; Fujifilm Holdings Corporation; Echosens SA
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Liver Disease Diagnostics Market Characteristics
3. Liver Disease Diagnostics Market Trends And Strategies
4. Liver Disease Diagnostics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Liver Disease Diagnostics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Liver Disease Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Liver Disease Diagnostics Market Growth Rate Analysis
- 5.4. Global Liver Disease Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Liver Disease Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Liver Disease Diagnostics Total Addressable Market (TAM)
6. Liver Disease Diagnostics Market Segmentation
- 6.1. Global Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Diagnosis Techniques
- 6.2. Global Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Non-Alcoholic Fatty Liver Disease
- Non-Alcoholic Steatohepatitis
- Fibrosis
- Cirrhosis
- Hepatocellular Carcinoma
- Other Diseases
- 6.3. Global Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Laboratories
- Other End Users
- 6.4. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Laboratory Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Blood Tests (Liver Function Tests, Hepatitis Panel)
- Enzyme Tests (ALT, AST, ALP)
- Genetic Testing
- Serological Tests
- 6.5. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Imaging, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Ultrasound Imaging
- CT Scans
- MRI
- Elastography (FibroScan)
- 6.6. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Endoscopy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Esophagogastroduodenoscopy (EGD)
- Capsule Endoscopy
- 6.7. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Liver Biopsy (Needle Biopsy)
- Fine Needle Aspiration Biopsy
- Laparoscopic Biopsy
- 6.8. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Other Diagnosis Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Molecular Imaging
- Biomarker Testing
- Fibrosis Scoring Systems
7. Liver Disease Diagnostics Market Regional And Country Analysis
- 7.1. Global Liver Disease Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Liver Disease Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Liver Disease Diagnostics Market
- 8.1. Asia-Pacific Liver Disease Diagnostics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Liver Disease Diagnostics Market
- 9.1. China Liver Disease Diagnostics Market Overview
- 9.2. China Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Liver Disease Diagnostics Market
- 10.1. India Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Liver Disease Diagnostics Market
- 11.1. Japan Liver Disease Diagnostics Market Overview
- 11.2. Japan Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Liver Disease Diagnostics Market
- 12.1. Australia Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Liver Disease Diagnostics Market
- 13.1. Indonesia Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Liver Disease Diagnostics Market
- 14.1. South Korea Liver Disease Diagnostics Market Overview
- 14.2. South Korea Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Liver Disease Diagnostics Market
- 15.1. Western Europe Liver Disease Diagnostics Market Overview
- 15.2. Western Europe Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Liver Disease Diagnostics Market
- 16.1. UK Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Liver Disease Diagnostics Market
- 17.1. Germany Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Liver Disease Diagnostics Market
- 18.1. France Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Liver Disease Diagnostics Market
- 19.1. Italy Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Liver Disease Diagnostics Market
- 20.1. Spain Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Liver Disease Diagnostics Market
- 21.1. Eastern Europe Liver Disease Diagnostics Market Overview
- 21.2. Eastern Europe Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Liver Disease Diagnostics Market
- 22.1. Russia Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Liver Disease Diagnostics Market
- 23.1. North America Liver Disease Diagnostics Market Overview
- 23.2. North America Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Liver Disease Diagnostics Market
- 24.1. USA Liver Disease Diagnostics Market Overview
- 24.2. USA Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Liver Disease Diagnostics Market
- 25.1. Canada Liver Disease Diagnostics Market Overview
- 25.2. Canada Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Liver Disease Diagnostics Market
- 26.1. South America Liver Disease Diagnostics Market Overview
- 26.2. South America Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Liver Disease Diagnostics Market
- 27.1. Brazil Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Liver Disease Diagnostics Market
- 28.1. Middle East Liver Disease Diagnostics Market Overview
- 28.2. Middle East Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Liver Disease Diagnostics Market
- 29.1. Africa Liver Disease Diagnostics Market Overview
- 29.2. Africa Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Liver Disease Diagnostics Market Competitive Landscape And Company Profiles
- 30.1. Liver Disease Diagnostics Market Competitive Landscape
- 30.2. Liver Disease Diagnostics Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Echosens SA Overview, Products and Services, Strategy and Financial Analysis
31. Liver Disease Diagnostics Market Other Major And Innovative Companies
- 31.1. Boston Scientific Corporation
- 31.2. Laboratory Corporation of America Holdings
- 31.3. Quest Diagnostics Incorporated
- 31.4. Siemens Healthineers AG
- 31.5. bioMerieux SA
- 31.6. Genentech Inc.
- 31.7. Perspectum Diagnostics Ltd.
- 31.8. Owlstone Medical Ltd.
- 31.9. Enterome SA
- 31.10. Atlentis Therapeutics AG
- 31.11. 89bio Inc.
- 31.12. Aligos Therapeutics Inc.
- 31.13. BioPredictive SAS
- 31.14. Cosara Diagnostics Pvt. Ltd.
- 31.15. Hepion Pharmaceuticals Inc.
32. Global Liver Disease Diagnostics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Liver Disease Diagnostics Market
34. Recent Developments In The Liver Disease Diagnostics Market
35. Liver Disease Diagnostics Market High Potential Countries, Segments and Strategies
- 35.1 Liver Disease Diagnostics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Liver Disease Diagnostics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Liver Disease Diagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
